AMP Meritorious Service Award 2018

202 Pages·2017·13.46 MB·English

Map the tumor
microenvironment
Introducing GeoMx™
Digital Spatial Profiler –
your GPS for immuno-oncology
Quantify and locate up to 1000 RNA or Protein
targets on a single slide with no tissue loss.
Visit us at booth #888
Table of Contents
General Information
Welcome from the AMP Program Chair 2
Code of Conduct 7
Maps (Convention Center & HQ Hotels) 9
Highlights & General Information 13
AMP Central Schedule 23
Award for Excellence 2018 Recipient 25
Jeffrey A. Kant Leadership Award 2018 Recipient 26
Meritorious Service Award 2018 Recipient 27
2018 Travel Award Recipients 28
Board, Committee and Working Group Rosters 2018 29
Continuing Education
Continuing Education Information 43
Continuing Education Tracker 50
Program
Program-at-a-Glance 53
Program Listing 54
Thursday Program
Thursday Session Descriptions 71
Friday Program
Friday Session Descriptions 79
Saturday Program
Saturday Session Descriptions 89
Speaker Information
Speaker Bios 99
Poster Information
Poster Information 121
Poster Listing 122
Author Index 149
Expo Information
Explore the Expo Hall – Expo Information 171
Expo Floor Plan / Hours & Dates 172
Exhibitor Listing 174
Exhibitor Descriptions 176
6120 Executive Blvd, Suite 700 • Rockville, MD 20852
301-634-7987 • [email protected]
Welcome
2018
to the
Association for Molecular
Pathology Annual Meeting & EXPO!
It is my honor and great pleasure to welcome you to the
2018 AMP Annual Meeting and Expo. The theme of our
meeting this year is “Precision Medicine Starts Here”.
The Precision Medicine Initiative of the National Institutes
of Health defines precision medicine as “an emerging
approach for disease treatment and prevention that takes
into account individual variability in genes, environment,
and lifestyle for each person.” For an increasing number
of diseases across a wide variety of medical specialties,
the one-size-fits-all approach to patient diagnosis and
treatment is becoming obsolete. As molecular pathology
professionals, we lead the way in developing and
applying new technologies to achieve the best patient
care and outcome in this rapidly evolving field. We also
play a vital role in educating our clinical colleagues, lay
public, and elected officials of the value of the critical
work that we do.
Our Program Committee has worked hard to plan this year’s program. A major goal was to
invite outstanding speakers whose work would be of broad interest across subdivisions,
which we hope will encourage dialogue and foster discussion among attendees who work
in different areas of molecular pathology. We believe that we have succeeded.
One of those outstanding speakers, the recipient of the AMP Award for Excellence in
Molecular Diagnostics, Dr. Jonathan Rothberg, will talk on “Reimagining Healthcare: Next
Generation DNA Sequencing to Ultrasound-on-a-Chip.” Dr. Rothberg is recognized for
his pioneering work in genomics, proteomics, and the development DNA sequencing
technologies. He is also an entrepreneur who has founded several major biotechnology
companies, whose technology we use daily in our molecular diagnostics laboratories.
Planning and assembling a program for the annual meeting takes tremendous effort from
the Planning Committee and the AMP staff. It is, without a doubt, a team effort. Chairing
this committee is the easy part. The real work is done by the committee members and AMP
staff. In addition to biweekly teleconferences to plan the program content, the committee
members spent many additional hours identifying and inviting exciting speakers. I would
like to recognize all of the subdivision committee members: Linda Jo Bone Jeng and Elaine
Spector (Genetics), Eric Duncavage and Lynn Wang (Hematopathology), Belinda Yen-
Lieberman, Jennifer Dien Bard, and David Hillyard (Infectious Diseases), Somak Roy and
Matthew Lebo (Informatics), Lynette Marie Sholl and Christina Lockwood (Solid Tumors),
Lynne Whetsell and Fernanda Sabato (Technical Topics), and Neal Lindeman, the incoming
Program Chair. AMP committee members/volunteer groups are shaping and leading the
field. Check out the many accomplishments and ongoing projects by reading the AMP
Committee Reports on the AMP Website (https://www.amp.org/about/committees/) or in
the Annual Meeting & Expo Mobile App.
2
#AMP2018
I would like to continue to extend my thanks to the AMP staff. They are models of
organization, efficiency, and grace under pressure. Special thanks go to Sara Hamilton and
Teniola Ayeni, who guided and supported the committee through the entire process of
creating the program. Their expertise was invaluable. They coordinated and facilitated the
teleconferences, organized the program, and kept us on task, which was not always easy.
Many thanks also go to Lucia Barker and Kathleen Carmody, who coordinated the abstract
submission and review processes. I also extend my sincere thanks to Tara Burke, Elisabeth
Campbell, Eriko Clements, Rhonda Jenkins, Jon Korman, Laurie Menser, Andy Noble, Mrudula
Pullambhatla, TaNika Switzer, Robyn Temple-Smolkin, Sarah Thibault-Sennett, Michele Zink,
and Mary Steele Williams.
I would also like to thank our corporate sponsors and exhibitors, who have helped
support our 2018 meeting. I would encourage you to attend our Corporate Workshops on
Wednesday, October 31, to learn about the newest technologies in our rapidly evolving field.
Finally, many thanks to our attendees and the entire membership for making our meeting
the premier gathering of molecular pathology professionals. This is THE place to network
and get connected and involved. Please take advantage of everything the Annual Meeting &
Expo has to offer.
Have a great time in San Antonio, y’all!
From the 2018 Program Committee,
Lynne V. Abruzzo
Lynne V. Abruzzo, MD, PhD
2018 Program Committee Chair
3
Precision Medicine Starts Here
NOTES
4
#AMP2018
Bristol-Myers Squibb: at the forefront
of Immuno-Oncology research
Precision
Medicine
Starts with
Pathology
G
E
N
E
R
At Bristol-Myers Squibb, we recognize
A
pathologists play a crucial role in furthering L

I
N
advancements that may help predict which
F
O
patients are likely to benefit from
R
Immuno-Oncology therapies. M
A
T
I
O
To learn more, visit us at Booth 924 N
at the Association for Molecular
Pathology Annual Meeting in
San Antonio, November 1–3, 2018
The sponsor of this ad verifies that they had no input into decision
making regarding selection of educational programs, content, or
faculty for this 2018 Annual Meeting.
For more information, please visit IOHCP.com and our
YouTube channel at youtube.com/bmsIOresearch.
© 2018 Bristol-Myers Squibb Company. All rights reserved. Printed in USA.
IOUS1803476-03-01 10/18
IOUS1803476-03-01_AMP_Program_Ad_R03.indd 1 10/4/18 1:12 PM
AMP_FP.qxp_Layout 1 9/28/18 11:36 AM Page 1
Simply
Silaris.
N
O
ATI THRU DECEMBER 31ST
M
R
O
F
N
I

L
A
R
E
N
E
G
INTRODUCING

SILARIS™
INFLUENZA A&B TEST
PCR Molecular
Testing At The
Point Of Care
l Accurate
l Affordable
l Simple
For more information
visit us at silaris.com.
For In Vitro Diagnostic Use Only
© 2018 Sekisui Diagnostics, LLC. All rights reserved. Because every result matters™
and Silaris™are trademarks of Sekisui Diagnostics, LLC.
AMP_FP.qxp_Layout 1 9/28/18 11:36 AM Page 1
AMP 2018 Annual Meeting & Expo
Simply
Code of Conduct
The Association for Molecular Pathology (AMP) is
committed to providing a friendly, safe, and welcoming
Silaris.
environment for all, regardless of gender, sexual G
orientation, disability, race, ethnicity, religion, national E
N
origin, age, gender identity, or any other demographic
E
group. We expect all attendees, media, speakers, AMP R
A
staff and volunteers, venue staff, contractors, guests, and L

exhibitors to help us ensure a safe and positive annual IN
meeting experience for everyone. F
O
R
M
A
While we cannot influence behavior outside of the official AMP annual meeting hours,
T
we expect all participants at the AMP 2018 Annual Meeting & Expo to abide by this IO
Code of Conduct in all venues, including ancillary events and all social gatherings. N
All participants are responsible for their own conduct. Anyone who is the recipient of
THRU DECEMBER 31ST unacceptable behavior should feel free to speak up without any fear of recrimination.
• AMP holds its collegial community in high value. Do your part to give everyone
you encounter an enjoyable experience so they remember you and the
meeting favorably.
• Exercise consideration and respect in your speech and actions.
• Abstain from all demeaning, discriminatory, or harassing behavior and speech.
• Respect the fact that slides and posters may include unpublished work so do
not photograph them without the presenter’s express permission.
• Be mindful of your surroundings and of your fellow participants. Alert Security
Personnel or call 911 if you notice a dangerous situation or someone in distress.
• Notify AMP Staff of any violation of this Code of Conduct that you experience
or observe.
INTRODUCING

SILARIS™ Unacceptable Behaviors
INFLUENZA A&B TEST
Unacceptable Behaviors Include:
PCR Molecular • Intimidating, harassing, abusive, discriminatory, derogatory or demeaning
Testing At The speech or actions
• Harmful or prejudicial verbal or written comments, jokes, or visual images
Point Of Care
related to gender, sexual orientation, disability, race, ethnicity, religion, national
l Accurate origin, age, gender identity, or any other demographic group
l Affordable • Use of provocative and/or sexual images, including in presentation slides and
exhibit booths
l Simple • Deliberate intimidation, stalking, or following
For more information • Harassing photography
visit us at silaris.com.
For In Vitro Diagnostic Use Only
7
© 2018 Sekisui Diagnostics, LLC. All rights reserved. Because every result matters™
and Silaris™are trademarks of Sekisui Diagnostics, LLC. Precision Medicine Starts Here
• Photographing slides of oral presentations and posters without the express
permission of the presenter/author
N • Recording of scientific and other sessions without the express permission of
O the presenter(s)
TI • Undue disruption of scientific sessions or other events
A
• Unwelcome and uninvited attention or contact
M
R • Physical assault, including unwelcome touch or groping
O • Real or implied threat of physical harm
F
N • Real or implied threat of professional or financial damage or harm
I

L
A
R What to Do if You Observe or Experience Conduct that
E
N
Violates this Code:
E
G
Please contact the nearest AMP or Security Staff. All reports will be kept confidential to
the extent possible. If you believe the situation is an emergency, call 911.
AMP Staff will help participants contact convention center/hotel/venue security or
local law enforcement authorities, and otherwise assist those experiencing conduct
that violates this Code. We value your attendance, and want your experience to be
professionally rewarding and personally enjoyable.
Consequences of Unacceptable Behavior
Unacceptable behavior from any participant at the AMP 2018 Annual Meeting & Expo,
including attendees, media, presenters, AMP staff and volunteers, venue staff, guests,
and exhibitors, will not be tolerated. Anyone asked to stop unacceptable behavior is
expected to comply immediately.
If a participant engages in unacceptable behavior, the AMP Executive Director will
determine appropriate action to be taken immediately, if any, which may include
expulsion from the AMP 2018 Annual Meeting & Expo, without refund, and/or contacting
local law enforcement authorities. The Board of Directors may consider the matter for
additional action.
See also the AMP Scientific Integrity Policy for Submission of Abstracts available in the
Abstracts/Posters section of the AMP 2018 Annual Meeting & Expo website.
8
#AMP2018